Epigenomics
Volume 15, 2023 - Issue 18
Research Article
SIX4, a Potential Therapeutic Target for Estrogen Receptor-Positive Breast Cancer Patients, is Associated with low Promoter Methylation Level
Hua-Tao Wu1 Department of General Surgery, First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China;2 Laboratory for Diagnosis & Treatment of Breast Cancer, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China
https://orcid.org/0000-0002-1640-6094
https://orcid.org/0000-0002-1640-6094, Zheng Wu3 The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China;4 Department of Physiology/Changjiang Scholar’s Laboratory, Shantou University Medical College, Shantou, 515041, Chinahttps://orcid.org/0000-0002-1393-7586
https://orcid.org/0000-0002-1393-7586, , , , , & Jing Liu3 The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China;4 Department of Physiology/Changjiang Scholar’s Laboratory, Shantou University Medical College, Shantou, 515041, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-7483-4572
https://orcid.org/0000-0002-7483-4572 show all